Mechanically Ventilated Patients
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Humanwell PharmaceuticalMO - Ballwin
2 programs2
Remimazolam besylatePhase 21 trial
Remimazolam besylatePhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
Humanwell PharmaceuticalRemimazolam besylate
Humanwell PharmaceuticalRemimazolam besylate
Clinical Trials (2)
PK/PD Properties and Safety of Remazolam Besylate for Injection in ICU Patients With Impaired Renal Function
Start: Nov 2023Est. completion: Dec 2024
Phase 2Unknown
Step 1 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients
Start: Apr 2022Est. completion: Feb 2023
Phase 2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space